NASDAQ:NXTC
NextCure, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.nextcure.comipo date
May 09, 2019
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, whi...Show More
Earnings
Earnings Release in 5 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus